Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Peptide Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115109118A introduces a solid-phase synthesis method for DS-8201 intermediates, offering superior purity and cost reduction for ADC manufacturing.
Novel fragment condensation method for Tesamorelin improves purity and yield. Ideal for pharmaceutical intermediates manufacturing and large-scale production.
Patent CN119080911B reveals modified Gly-AM resin method improving yield and purity for scalable manufacturing. Enhances supply chain reliability for global pharmaceutical partners seeking cost efficiency.
Patent CN113461773A reveals a high-yield liquid phase route for LKP tripeptide. Discover cost-effective manufacturing strategies for ACE inhibitory peptides.
Patent CN114213503A details a novel phthaloyl-based liquid phase synthesis for snake venom tripeptide, offering significant cost reduction and eliminating heavy metal catalysts for cosmetic manufacturers.
Patent CN112480206A reveals a novel aminolysis route for L-carnosine, offering high selectivity and cost reduction in pharmaceutical manufacturing without complex histidine protection.
Patent CN111690037A details a novel GHK acetate synthesis using activated esters and ion exchange, ensuring high purity and cost reduction in cosmetic peptide manufacturing.
Discover the novel Alloc-protected solid-phase synthesis of Somatostatin KE108. Eliminating hydrogen hazards for safer, scalable pharmaceutical intermediate production.
Patent CN112538103B reveals a safer, hydrogen-free synthesis route for Somatostatin KE108 using Alloc protection, offering significant cost reduction in peptide manufacturing.
Patent CN113801199A details a novel Mitsunobu cyclization for Carbetocin. Discover cost-effective, scalable solid-phase manufacturing solutions for this oxytocin analogue.
Patent CN114230653B reveals a novel fragment coupling method for Chlorotoxin, achieving >99% purity. Discover cost-effective manufacturing strategies for this tumor-targeting peptide intermediate.
Patent CN114685645A details a novel Semaglutide synthesis using NCL and desulfurization, offering improved purity and cost reduction for API manufacturing.
Patent CN104987382B reveals hybrid liquid-solid peptide synthesis improving purity and yield. Offers substantial cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104496843B details a low-cost ubenimex synthesis route avoiding toxic resolving agents, offering significant supply chain and purity advantages for pharmaceutical manufacturers.
Patent CN103304659B reveals advanced solid-phase synthesis for Liraglutide. Enhances purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN107098950A reveals a condensing-agent-free method for GHK synthesis. Achieve over 97% purity with reduced production costs for cosmetic and pharmaceutical applications.
Patent CN112300250B details novel Anidulafungin analogs with improved solubility and reduced toxicity. Discover scalable synthesis routes for high-purity antifungal intermediates.
Advanced synthetic route for Daptomycin antibiotic using solid-liquid phase combination. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103880945A details a novel fragment condensation method for Thymalfasin, offering >99% purity and enhanced scalability for reliable pharmaceutical intermediate supply chains.
Patent CN111944037B reveals advanced solid-phase peptide synthesis reducing impurities. Enhances supply chain reliability and cost efficiency for global pharmaceutical manufacturers.